Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Janzon Pharma Consulting AB
AB
Dissolved
Org 5594216540
Falun
Business and other management consultancy activities
·
NACE 7020
Est. 2023 · 3 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Janzon Pharma Consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2023: 1M
1M
2023
2024: 1M (0% vs 2023)
1M
0%
2024
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
SEK thousands
Item
2024
2023
Revenue
560
1 195
Staff expenses
—
—
EBITDA
−163
353
Depreciation & amort.
−0
−0
EBIT
−163
353
Net financials
4
2
Profit before tax
−159
354
Tax
−73
−73
Net profit
−232
281
Balance sheet
SEK thousands
Item
2024
2023
Total assets
474
770
Equity
147
306
Long-term debt
0
0
Short-term debt
327
463
Total debt
327
463
Financial ratios
5-year trend
EBITDA margin
−29,1 %
This company
15,8 %
Market median
This company
Market median
284% below market
2023
2024
Equity ratio
31,0 %
This company
38,2 %
Market median
This company
Market median
19% below market
2023
2024
Return on equity
−157,8 %
This company
18,4 %
Market median
This company
Market median
958% below market
2023
2024
Net profit margin
−41,4 %
This company
8,1 %
Market median
This company
Market median
611% below market
2023
2024
Asset turnover
1,18×
This company
1,12×
Market median
This company
Market median
5% above market
2023
2024
Debt / equity
2,22×
This company
0,62×
Market median
This company
Market median
258% above market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-02-01 – 2023-12-31
View
PDF
More on Janzon Pharma Consulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network